Neuromuscular Disorders
Volume 19, Issue 12 , Pages 837-840, December 2009

Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity

  • Roberto Massa

      Affiliations

    • Department of Neurosciences, University of Rome-Tor Vergata and IRCCS-Fondazione S. Lucia, Via Montpellier 1, I-00135 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 72596004; fax: +39 06 72596022.
  • ,
  • Alessandra Tessa

      Affiliations

    • Molecular Medicine & Neurosciences, IRCCS-Bambino Gesù Hospital, Rome, Italy
  • ,
  • Maria Margollicci

      Affiliations

    • Laboratory of Metabolic Genetics, Department of Pediatrics, University of Siena, Siena, Italy
  • ,
  • Vanna Micheli

      Affiliations

    • Section of Biochemistry, University of Siena, Siena, Italy
  • ,
  • Andrea Romigi

      Affiliations

    • Department of Neurosciences, University of Rome-Tor Vergata and IRCCS-Fondazione S. Lucia, Via Montpellier 1, I-00135 Rome, Italy
  • ,
  • Giulia Tozzi

      Affiliations

    • Molecular Medicine & Neurosciences, IRCCS-Bambino Gesù Hospital, Rome, Italy
  • ,
  • Chiara Terracciano

      Affiliations

    • Department of Neurosciences, University of Rome-Tor Vergata and IRCCS-Fondazione S. Lucia, Via Montpellier 1, I-00135 Rome, Italy
  • ,
  • Fiorella Piemonte

      Affiliations

    • Molecular Medicine & Neurosciences, IRCCS-Bambino Gesù Hospital, Rome, Italy
  • ,
  • Giorgio Bernardi

      Affiliations

    • Department of Neurosciences, University of Rome-Tor Vergata and IRCCS-Fondazione S. Lucia, Via Montpellier 1, I-00135 Rome, Italy
  • ,
  • Filippo M. Santorelli

      Affiliations

    • Molecular Medicine & Neurosciences, IRCCS-Bambino Gesù Hospital, Rome, Italy

Received 3 July 2009; received in revised form 10 August 2009; accepted 27 August 2009.

Abstract 

Mitochondrial NeuroGastroIntestinal Encephalomyopathy (MNGIE) is an autosomal recessive disorder characterized by severe gastrointestinal dysmotility, cachexia, peripheral neuropathy, ptosis, ophthalmoplegia, and leukoencephalopathy with early onset and severe prognosis. Mutations in the TYMP/ECGF1 gene cause a loss of thymidine phosphorylase catalytic activity, disrupting the homeostasis of intramitochondrial nucleotide pool. We report a woman with a very late onset of MNGIE, lacking peripheral neuropathy. Thymidine phosphorylase activity was markedly reduced in cultured fibroblasts, but only mildly reduced in buffy coat, where the defect is usually detected, and plasma thymidine was mildly increased compared to typical MNGIE patients. TYMP/ECGF1 analysis detected two heterozygous mutations, including a novel missense mutation. These findings indicate that a partial loss of thymidine phosphorylase activity may induce a late-onset and incomplete MNGIE phenotype.

Keywords: MNGIE, Mitochondrial disease, Peripheral neuropathy, Late-onset, Thymidine phosphorylase, TYMP/ECGF1 mutations

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0960-8966(09)00594-X

doi:10.1016/j.nmd.2009.08.013

Neuromuscular Disorders
Volume 19, Issue 12 , Pages 837-840, December 2009